This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Eastman Chemical (EMN) Raises Prices of Glycol Products
by Zacks Equity Research
Eastman Chemical (EMN) raises off-list prices of products in North America.
Robust Markets Aid International Flavors, Higher Costs Hurt
by Zacks Equity Research
Focus to drive greater efficiencies through costs and productivity initiatives as well as favorable taxes continue to support overall profitability for International Flavors & Fragrances (IFF).
5 Reasons to Add Mosaic (MOS) Stock to Your Portfolio Now
by Zacks Equity Research
Strong fundamentals and upbeat prospects make Mosaic (MOS) an attractive investment choice.
Methanex Inks Natural Gas Supply Deals for Chile Operations
by Zacks Equity Research
Natural gas supply agreements allow Methanex (MEOH) for a two-plant operation in Chile.
Cosan's (CZZ) Q2 Net Income Surges 104%, Revenues Up Y/Y
by Zacks Equity Research
Cosan's (CZZ) near-term performance will likely be impacted by challenging economic conditions in Brazil as well as unfavorable weather.
7 Factors Why Domtar is a Solid Investment Choice For 2018
by Zacks Equity Research
Steady performance, positive estimate revisions, healthy growth prospects are likely to help Domtar Corporation (UFS) grow further.
Celanese (CE) to Hike Prices of Acetyl Intermediates Products
by Zacks Equity Research
Celanese (CE) set to raise list and off-list selling prices of acetyl intermediates products.
Air Products (APD) Enters into $8B JV at Jazan Economic City
by Zacks Equity Research
Air Products (APD) will own at least 55% of the JV that will produce hydrogen, power and other utilities for Saudi Aramco.
5 Reasons That Make Ingevity (NGVT) a Solid Choice Now
by Anindya Barman
Healthy growth prospects and upbeat outlook make Ingevity (NGVT) an attractive investment option.
Here's Why You Should Add Huntsman (HUN) to Your Portfolio
by Anindya Barman
Based on its compelling prospects, we believe Huntsman (HUN) has plenty of upside potential.
Pan American Silver (PAAS) Tops Q2 Earnings & Sales Estimates
by Zacks Equity Research
Pan American Silver's (PAAS) Q2 results benefit from record low cash costs, courtesy of higher by-product credits and throughput as well as lower refining charges.
Valmont (VMI) Buys Walpar, Expands in Sign Structures Market
by Zacks Equity Research
The acquisition strengthens Valmont's (VMI) foothold in the sign structures market.
Koppers (KOP) Earnings & Revenues Trail Estimates in Q2
by Anindya Barman
Koppers (KOP) reaffirmed its adjusted earnings guidance at the range of $4.05 and $4.25 per share for 2018.
Andersons (ANDE) Q2 Earnings Top, Revenues Miss Estimates
by Zacks Equity Research
Andersons (ANDE) anticipated to benefit from strong domestic and export demand despite the impact of current tariffs and trade disputes.
Valmont (VMI) Buys Derit, Enters Lattice Structures Market
by Zacks Equity Research
Valmont (VMI) is poised to benefit from Derit's 40,000 metric tons of lattice manufacturing capacity.
Kronos Worldwide (KRO) Lags Q2 Earnings & Sales Estimates
by Zacks Equity Research
Lower TiO2 production and sales volumes on a year-over-year basis hurt Kronos Worldwide's (KRO) Q2 earnings.
Albemarle (ALB) Looks Good: Stock Adds 6.4% in Session
by Zacks Equity Research
Albemarle (ALB) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
American Vanguard (AVD) Q2 Earnings Top, Sales Miss Estimates
by Anindya Barman
American Vanguard (AVD) sees strong performance across a number of major components of its business through the remainder of 2018.
Innospec (IOSP) Q2 Earnings Miss Estimates, Sales Up Y/Y
by Zacks Equity Research
While Innospec (IOSP) saw higher sales across its core business units in Q2, its earnings miss expectations.
Versum Materials (VSM) Q3 Earnings & Revenues Top Estimates
by Zacks Equity Research
Versum Materials (VSM) has narrowed its total sales and adjusted EBITDA guidance for fiscal 2018.
Albemarle (ALB) Tops Q2 Earnings Estimates, Raises FY18 View
by Anindya Barman
Albemarle (ALB) raised its adjusted earnings outlook for 2018 to $5.30-$5.50 per share.
Cabot (CBT) Earnings and Revenues Trump Estimates in Q3
by Zacks Equity Research
Cabot (CBT) expects strong performance across all segments in Q4.
Kinross (KGC) Q2 Earnings In Line, Revenues Miss Estimates
by Zacks Equity Research
Lower production and a decrease in gold equivalent ounces sold impacts Kinross' (KGC) performance in Q2.
Mosaic's (MOS) Q2 Earnings Beat Estimates, FY18 View Up
by Anindya Barman
Mosaic (MOS) bumped up its adjusted earnings guidance for 2018 to $1.45-$1.80 per share.
Scotts Miracle-Gro (SMG) Q3 Earnings Top, Sales Lag Estimates
by Zacks Equity Research
Scotts Miracle-Gro (SMG) reiterates its adjusted earnings outlook for fiscal 2018 in the range of $3.70-$3.90 per share.